255 related articles for article (PubMed ID: 29202480)
1. Differential impact of RB status on E2F1 reprogramming in human cancer.
McNair C; Xu K; Mandigo AC; Benelli M; Leiby B; Rodrigues D; Lindberg J; Gronberg H; Crespo M; De Laere B; Dirix L; Visakorpi T; Li F; Feng FY; de Bono J; Demichelis F; Rubin MA; Brown M; Knudsen KE
J Clin Invest; 2018 Jan; 128(1):341-358. PubMed ID: 29202480
[TBL] [Abstract][Full Text] [Related]
2. RB/E2F1 as a Master Regulator of Cancer Cell Metabolism in Advanced Disease.
Mandigo AC; Yuan W; Xu K; Gallagher P; Pang A; Guan YF; Shafi AA; Thangavel C; Sheehan B; Bogdan D; Paschalis A; McCann JJ; Laufer TS; Gordon N; Vasilevskaya IA; Dylgjeri E; Chand SN; Schiewer MJ; Domingo-Domenech J; Den RB; Holst J; McCue PA; de Bono JS; McNair C; Knudsen KE
Cancer Discov; 2021 Sep; 11(9):2334-2353. PubMed ID: 33879449
[TBL] [Abstract][Full Text] [Related]
3. Novel Oncogenic Transcription Factor Cooperation in RB-Deficient Cancer.
Mandigo AC; Shafi AA; McCann JJ; Yuan W; Laufer TS; Bogdan D; Gallagher L; Dylgjeri E; Semenova G; Vasilevskaya IA; Schiewer MJ; McNair CM; de Bono JS; Knudsen KE
Cancer Res; 2022 Jan; 82(2):221-234. PubMed ID: 34625422
[TBL] [Abstract][Full Text] [Related]
4. Retinoblastoma (Rb) tumor-suppressor pathway alterations in meningeal hemangiopericytomas: High E2F transcription factor 1 expression and loss of Rb expression: study by double immunofluorescence staining and laser-scanning confocal microscopy.
Martinez JC; Palomino JC; Samaniego R; Sepulveda JM; Cabello A; Ricoy JR
Cancer; 2008 Jul; 113(1):166-74. PubMed ID: 18459177
[TBL] [Abstract][Full Text] [Related]
5. Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells.
Davis JN; McCabe MT; Hayward SW; Park JM; Day ML
Cancer Res; 2005 May; 65(9):3633-42. PubMed ID: 15867358
[TBL] [Abstract][Full Text] [Related]
6. Genomic instability and proliferation/survival pathways in RB1-deficient malignancies.
Pappas L; Xu XL; Abramson DH; Jhanwar SC
Adv Biol Regul; 2017 May; 64():20-32. PubMed ID: 28242412
[TBL] [Abstract][Full Text] [Related]
7. LIMD1 antagonizes E2F1 activity and cell cycle progression by enhancing Rb function in cancer cells.
Mayank AK; Sharma S; Deshwal RK; Lal SK
Cell Biol Int; 2014 Jul; 38(7):809-17. PubMed ID: 24523249
[TBL] [Abstract][Full Text] [Related]
8. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses.
Liu Y; Zacksenhaus E
Oncogene; 2000 Dec; 19(52):6065-73. PubMed ID: 11146559
[TBL] [Abstract][Full Text] [Related]
9. Retinoblastoma tumor suppressor status is a critical determinant of therapeutic response in prostate cancer cells.
Sharma A; Comstock CE; Knudsen ES; Cao KH; Hess-Wilson JK; Morey LM; Barrera J; Knudsen KE
Cancer Res; 2007 Jul; 67(13):6192-203. PubMed ID: 17616676
[TBL] [Abstract][Full Text] [Related]
10. The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression.
Sharma A; Yeow WS; Ertel A; Coleman I; Clegg N; Thangavel C; Morrissey C; Zhang X; Comstock CE; Witkiewicz AK; Gomella L; Knudsen ES; Nelson PS; Knudsen KE
J Clin Invest; 2010 Dec; 120(12):4478-92. PubMed ID: 21099110
[TBL] [Abstract][Full Text] [Related]
11. E2F1 loss induces spontaneous tumour development in Rb-deficient epidermis.
Costa C; Santos M; Martínez-Fernández M; Dueñas M; Lorz C; García-Escudero R; Paramio JM
Oncogene; 2013 Jun; 32(24):2937-51. PubMed ID: 22890321
[TBL] [Abstract][Full Text] [Related]
12. RB localizes to DNA double-strand breaks and promotes DNA end resection and homologous recombination through the recruitment of BRG1.
Vélez-Cruz R; Manickavinayaham S; Biswas AK; Clary RW; Premkumar T; Cole F; Johnson DG
Genes Dev; 2016 Nov; 30(22):2500-2512. PubMed ID: 27940962
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
[TBL] [Abstract][Full Text] [Related]
14. Annexin-A7 protects normal prostate cells and induces distinct patterns of RB-associated cytotoxicity in androgen-sensitive and -resistant prostate cancer cells.
Torosyan Y; Simakova O; Naga S; Mezhevaya K; Leighton X; Diaz J; Huang W; Pollard H; Srivastava M
Int J Cancer; 2009 Dec; 125(11):2528-39. PubMed ID: 19610065
[TBL] [Abstract][Full Text] [Related]
15. Life, death and E2F: linking proliferation control and DNA damage signaling via E2F1.
Rogoff HA; Kowalik TF
Cell Cycle; 2004 Jul; 3(7):845-6. PubMed ID: 15190206
[TBL] [Abstract][Full Text] [Related]
16. Human herpesvirus 6A (HHV-6A) and HHV-6B alter E2F1/Rb pathways and E2F1 localization and cause cell cycle arrest in infected T cells.
Mlechkovich G; Frenkel N
J Virol; 2007 Dec; 81(24):13499-508. PubMed ID: 17913805
[TBL] [Abstract][Full Text] [Related]
17. The E2F1/Rb and p53/MDM2 pathways in DNA repair and apoptosis: understanding the crosstalk to develop novel strategies for prostate cancer radiotherapy.
Udayakumar T; Shareef MM; Diaz DA; Ahmed MM; Pollack A
Semin Radiat Oncol; 2010 Oct; 20(4):258-66. PubMed ID: 20832018
[TBL] [Abstract][Full Text] [Related]
18. The Role of RB in Prostate Cancer Progression.
Burkhart DL; Morel KL; Sheahan AV; Richards ZA; Ellis L
Adv Exp Med Biol; 2019; 1210():301-318. PubMed ID: 31900914
[TBL] [Abstract][Full Text] [Related]
19. The conflicting role of E2F1 in prostate cancer: A matter of cell context or interpretational flexibility?
Chun JN; Cho M; Park S; So I; Jeon JH
Biochim Biophys Acta Rev Cancer; 2020 Jan; 1873(1):188336. PubMed ID: 31870703
[TBL] [Abstract][Full Text] [Related]
20. Rb-mediated neuronal differentiation through cell-cycle-independent regulation of E2f3a.
Chen D; Opavsky R; Pacal M; Tanimoto N; Wenzel P; Seeliger MW; Leone G; Bremner R
PLoS Biol; 2007 Jul; 5(7):e179. PubMed ID: 17608565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
